Eric Hsu
Corporate Officer/Principal at INMED PHARMACEUTICALS INC.
Net worth: 19 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eric Adams | M | 61 |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 18 years |
| Andrew Hull | M | 61 | 8 years | |
| Nicole Lemerond | F | 49 | 2 years | |
| Richard Glickman | M | 65 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 13 years |
| Michael Woudenberg | M | - | 6 years | |
| Bryan Baldasare | M | 58 | 2 years | |
| Janet Grove | F | 57 | 2 years | |
| Colin Clancy | M | - | - | |
| Samantha Nutt | M | - |
University of Toronto
| 27 years |
| Gerard Griffin | M | - | 2 years | |
| Dennis Langer | M | 73 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 9 years |
| Zheng-Hong Lu | M | - |
University of Toronto
| 26 years |
| Alexandra Mancini | F | - | - | |
| James E. Mungall | M | - |
University of Toronto
| 25 years |
| Steven Gannon | M | 62 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 7 years |
| Tony Naldrett | M | - |
University of Toronto
| 26 years |
| Andrei Vladimirovich Petrov | M | 50 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 9 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sazzad Hossain | M | - | 38 years | |
| David Naylor | M | 68 |
University of Toronto
| - |
| Garner William | M | 58 | 6 years | |
| Mary Anne V. Chambers | F | - |
University of Toronto
| 9 years |
| Larry Llaguno | M | - |
University of Toronto
| 12 years |
| Eric Josipovic | M | - |
University of Toronto
| 6 years |
| Daniel M. Miller | M | - |
University of Toronto
| 2 years |
| Catherine A. Sazdanoff | F | 68 | 3 years | |
| Tom Keefe | M | - |
University of Toronto
| 5 years |
| Martin Bott | M | - | 2 years | |
| Sandy Der | M | - |
University of Toronto
| 13 years |
| Robin Bienenstock | M | 55 |
University of Toronto
| 1 years |
| Meny Grauman | M | - |
University of Toronto
| 6 years |
| Alfred C. Sum | M | - |
University of Toronto
| 6 years |
| Matthew Come | M | 67 |
University of Toronto
| 3 years |
| Natasha Ann Sharpe | M | - |
University of Toronto
| - |
| Hussein Sunderji | M | - |
University of Toronto
| 9 years |
| Yousef Rehman | M | 42 |
University of Toronto
| 7 years |
| Joshua Gerstein | M | 51 |
University of Toronto
| 3 years |
| Bryan Edwin Rock | M | 45 |
University of Toronto
| 7 years |
| Adam Cilio | M | - |
University of Toronto
| 6 years |
| Adam Daniel Cutler | M | 50 | 7 years | |
| Michael Dolega | M | - |
University of Toronto
| 7 years |
| Joshua Blacher | M | 52 | 1 years | |
| Ricky Mehra | M | 45 |
University of Toronto
| 7 years |
| Shechar Dworski | M | - |
University of Toronto
| 6 years |
| Neil Seneviratne | M | - |
University of Toronto
| 4 years |
| Greg Payne | M | - |
University of Toronto
| 14 years |
| Jonathan Tegge | M | 34 | 2 years | |
| Jeffrey Charpentier | M | - | - | |
| Kathy-Ann Martin | F | 52 |
University of Toronto
| 4 years |
| Daniel Munro | M | - |
University of Toronto
| 5 years |
| Daniel Bringleson | M | - |
University of Toronto
| 4 years |
| Michael Raymond Mallinos | M | - |
University of Toronto
| 3 years |
| Tina Hsiao | F | - |
University of Toronto
| 4 years |
| Navin Dyal | M | 48 |
University of Toronto
| 5 years |
| Jon Case | M | - |
University of Toronto
| 4 years |
| Alexander E. Limion | M | - |
University of Toronto
| 2 years |
| George Lagoudakis | M | - |
University of Toronto
| 4 years |
| Yu Ting Freddy Goman Chong | M | 49 |
University of Toronto
| 4 years |
| Ronan Levy | M | 45 |
University of Toronto
| 4 years |
| Feng Guo | M | 54 |
University of Toronto
| 3 years |
| Yvonne Johnson | F | - |
University of Toronto
| 5 years |
| Asya Bradley | F | - |
University of Toronto
| 4 years |
| David Klein | M | - |
University of Toronto
| 4 years |
| Jade Rubick | M | - |
University of Toronto
| 3 years |
| Meredith Brill | F | 49 |
University of Toronto
| 4 years |
| Douglas Ching | M | - |
University of Toronto
| 4 years |
| Sonia Gokhale | F | - |
University of Toronto
| 4 years |
| John Kratochwil | M | - |
University of Toronto
| 4 years |
| Aleksander Migon | M | - |
University of Toronto
| 4 years |
| Orest Zajcew | M | 62 |
University of Toronto
| 3 years |
| Richard Gray | M | - |
University of Toronto
| 4 years |
| Robert Maxwell | M | - |
University of Toronto
| 2 years |
| Dominique Barker | F | 52 |
University of Toronto
| 2 years |
| John Charles Robert Aiken | M | - |
University of Toronto
| 2 years |
| Aleem Israel | M | - |
University of Toronto
| 2 years |
| David Tomljenovic | M | - |
University of Toronto
| 2 years |
| Jason Berenstein | M | - |
University of Toronto
| 2 years |
| Perry Ing | M | 48 |
University of Toronto
| 4 years |
| Osvaldo S. Matias | M | - |
University of Toronto
| 5 years |
| Mina Debra Marmor | M | - |
University of Toronto
| 3 years |
| Andrew Morris | M | - |
University of Toronto
| 2 years |
| Rick Lau | M | - |
University of Toronto
| 4 years |
| Gary Q. Lau | M | 51 |
University of Toronto
| 4 years |
| Charles Walter Lannon | M | - |
University of Toronto
| 4 years |
| Eric M. Meslin | M | - |
University of Toronto
| 8 years |
| Keyvan Mohajer | M | 46 |
University of Toronto
| 4 years |
| Reetu Kumra | F | - |
University of Toronto
| 4 years |
| Curtis Wee | M | - |
University of Toronto
| 4 years |
| Rabinder Grewal | F | - |
University of Toronto
| 4 years |
| Kam Wah Wong | M | 50 |
University of Toronto
| 4 years |
| Rusty Wong | M | - |
University of Toronto
| 4 years |
| Zhao Jie Li | M | 69 |
University of Toronto
| 3 years |
| Wing Tung Chow | M | 49 |
University of Toronto
| 4 years |
| Wai Leung Chan | M | 51 |
University of Toronto
| 4 years |
| Edward Sollbach | M | - |
University of Toronto
| 3 years |
| Johnson Wan | M | 44 |
University of Toronto
| 4 years |
| Heru Soesanto Riwanto | M | 45 |
University of Toronto
| 4 years |
| Leung Fai Yu | M | 48 |
University of Toronto
| 4 years |
| Irina Dorogan | F | - |
University of Toronto
| 5 years |
| Tyler Currie | M | - |
University of Toronto
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Hsu
- Personal Network
